Development of a Risk Nomogram Model for Identifying Interstitial Lung Disease in Patients With Rheumatoid Arthritis.
Development of a Risk Nomogram Model for Identifying Interstitial Lung Disease in Patients With Rheumatoid Arthritis.
复制标题
开发用于识别类风湿性关节炎患者间质性肺疾病的风险列线图模型
DOI:
10.3389/fimmu.2022.823669
复制
发表时间:
2022
影响因子:
7.3
通讯作者:
中科院分区:
文献类型:
--
作者:
The clinical features of rheumatoid arthritis (RA)-associated interstitial lung disease (ILD) (RA-ILD) usually manifest to an advanced stage of lung disease, which leads the challenge of early diagnosis and the difficulty in guiding treatments for patients with RA-ILD in clinical settings. The aim of this study was to construct a nomogram for identifying ILD in RA patients. Through the incorporation of the level of matrix metalloproteinase-3 (MMP-3) in plasma, demographics, clinical feature, and laboratory parameters of 223 RA patients (85 RA-ILD) which were grouped as training cohorts and validation cohorts, an identifying nomogram of RA-ILD was built. Candidate variables for the nomogram were screened using univariable analysis and multivariable logistic regression analysis. The accuracy of the diagnostic nomogram was measured via concordance index (C-index), calibration plots, and decision curve analysis (DCA). Results showed that plasma MMP-3 protein was elevated in RA-ILD patients compared with non-ILD RA patients in both training cohorts (p = 0.0475) and validation cohorts (p = 0.0006). Following a final regression analysis, the gender of male, current smoking state, levels of circulating rheumatoid factor (RF), C-reactive protein (CRP), and MMP-3 were identified as risk factors for the construction of the nomogram. The calibration plots further showed a favorable consistency between the identifying nomogram and actual clinical findings. In consistence, the C-index (0.826 for both training cohorts and validation cohorts) indicated the satisfactory discriminative ability of the nomogram. Although the incorporation of MMP-3 failed to significantly improve identified outcomes of the nomogram as determined by DCA, including the level of circulating MMP-3 increased the diagnostic accuracy of the nomogram for ILD in RA patients. Thus, our proposed model can serve as a non-invasive tool to identify ILD in RA patients, which may assist physicians to make treatment decisions for RA patients.
登录
查看更多内容
DOI:
10.3899/jrheum.200863
发表时间:
2021-05
期刊:
The Journal of rheumatology
影响因子:
--
作者:
Kronzer VL;Huang W;Dellaripa PF;Huang S;Feathers V;Lu B;Iannaccone CK;Gill RR;Hatabu H;Nishino M;Crowson CS;Davis JM 3rd;Weinblatt ME;Shadick NA;Doyle TJ;Sparks JA
通讯作者:
Sparks JA
DOI:
10.1002/art.38904
发表时间:
2015-01
期刊:
Arthritis & rheumatology (Hoboken, N.J.)
影响因子:
--
作者:
Chen J;Doyle TJ;Liu Y;Aggarwal R;Wang X;Shi Y;Ge SX;Huang H;Lin Q;Liu W;Cai Y;Koontz D;Fuhrman CR;Golzarri MF;Liu Y;Hatabu H;Nishino M;Araki T;Dellaripa PF;Oddis CV;Rosas IO;Ascherman DP
通讯作者:
Ascherman DP
影响因子:
--
作者:
Bongartz, Tim;Nannini, Carlotta;Medina-Velasquez, Yimy F.;Achenbach, Sara J.;Crowson, Cynthia S.;Ryu, Jay H.;Vassallo, Robert;Gabriel, Sherine E.;Matteson, Eric L.
通讯作者:
Matteson, Eric L.
DOI:
10.1016/s1470-2045(14)71116-7
发表时间:
2015-04
期刊:
The Lancet. Oncology
影响因子:
--
作者:
Balachandran VP;Gonen M;Smith JJ;DeMatteo RP
通讯作者:
DeMatteo RP
影响因子:
24.3
作者:
Buendia-Roldan, Ivette;Fernandez, Rosario;Selman, Moises
通讯作者:
Selman, Moises